Federal Project Grant Award Summary

AMG Detection, Inc. received a $305,000 Small Business Technology Transfer (STTR) Phase I award from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective July 1, 2026 through June 30, 2027. The company is developing a wearable carbon nanotube sensor array designed to predict epileptic seizures 10–45 minutes before onset by detecting nine pre-seizure volatile organic compounds (VOCs) emitted from the skin. This represents a significant advancement over existing seizure monitoring technologies, which only detect seizures after they occur and generate high false-positive rates due to reliance on indirect physiological signals.

The project delivers a scalable, non-invasive wearable device intended for commercial deployment through both clinical and direct-to-consumer markets via a subscription-based model. By enabling advance warning of seizures, the technology addresses a critical unmet need in epilepsy management affecting 3.4 million Americans, with potential to reduce seizure-related injuries, emergency interventions, and loss of independence during high-risk activities. Successful commercialization would establish a new category of predictive neurological monitoring and create a foundation for broader applications of chemical biosensing in acute neurological and cardiovascular conditions. The work is performed in Johns Creek, Georgia.